[{"address1": "175 Innovation Boulevard", "city": "Wilmington", "state": "DE", "zip": "19805", "country": "United States", "phone": "302 467 1280", "website": "https://preludetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.", "fullTimeEmployees": 131, "companyOfficers": [{"maxAge": 1, "name": "Dr. Krishna  Vaddi D.V.M., Ph.D.", "age": 58, "title": "Founder, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 881092, "exercisedValue": 0, "unexercisedValue": 12515}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.35, "open": 1.33, "dayLow": 1.19, "dayHigh": 1.33, "regularMarketPreviousClose": 1.35, "regularMarketOpen": 1.33, "regularMarketDayLow": 1.19, "regularMarketDayHigh": 1.33, "payoutRatio": 0.0, "beta": 1.064, "forwardPE": -0.7880795, "volume": 1043071, "regularMarketVolume": 1043071, "averageVolume": 1271048, "averageVolume10days": 6720880, "averageDailyVolume10Day": 6720880, "bid": 1.17, "ask": 1.23, "bidSize": 2, "askSize": 1, "marketCap": 67354416, "fiftyTwoWeekLow": 0.61, "fiftyTwoWeekHigh": 4.22, "allTimeHigh": 95.375, "allTimeLow": 0.61, "priceToSalesTrailing12Months": 9.62206, "fiftyDayAverage": 1.3809, "twoHundredDayAverage": 1.00416, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 35298716, "profitMargins": 0.0, "floatShares": 18264195, "sharesOutstanding": 43750086, "sharesShort": 515090, "sharesShortPriorMonth": 538367, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0091, "heldPercentInsiders": 0.113570005, "heldPercentInstitutions": 0.62352, "shortRatio": 1.79, "shortPercentOfFloat": 0.0685, "impliedSharesOutstanding": 56600345, "bookValue": 0.996, "priceToBook": 1.1947792, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -124318000, "trailingEps": -1.64, "forwardEps": -1.51, "enterpriseToRevenue": 5.043, "enterpriseToEbitda": -0.265, "52WeekChange": 0.0, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 1.19, "targetHighPrice": 5.0, "targetLowPrice": 3.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 73216000, "totalCashPerShare": 0.962, "ebitda": -133245000, "totalDebt": 17917000, "quickRatio": 3.502, "currentRatio": 3.677, "totalRevenue": 7000000, "debtToEquity": 23.625, "revenuePerShare": 0.092, "returnOnAssets": -0.49751, "returnOnEquity": -0.96328, "grossProfits": 7000000, "freeCashflow": -68643376, "operatingCashflow": -108346000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -19.28671, "financialCurrency": "USD", "symbol": "PRLD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Prelude Therapeutics Incorporat", "longName": "Prelude Therapeutics Incorporated", "marketState": "CLOSED", "exchange": "NMS", "messageBoardId": "finmb_373775974", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.19089997, "fiftyDayAverageChangePercent": -0.13824315, "twoHundredDayAverageChange": 0.18584001, "twoHundredDayAverageChangePercent": 0.18507011, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-25", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601040600000, "postMarketChangePercent": 2.3193219, "postMarketPrice": 1.2176, "postMarketChange": 0.02759993, "regularMarketChange": -0.16, "regularMarketDayRange": "1.19 - 1.33", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1271048, "corporateActions": [], "postMarketTime": 1762563598, "regularMarketTime": 1762549200, "regularMarketChangePercent": -11.8518, "regularMarketPrice": 1.19, "fiftyTwoWeekLowChange": 0.58000004, "fiftyTwoWeekLowChangePercent": 0.95081973, "fiftyTwoWeekRange": "0.61 - 4.22", "fiftyTwoWeekHighChange": -3.0299997, "fiftyTwoWeekHighChangePercent": -0.7180095, "fiftyTwoWeekChangePercent": 0.0, "earningsTimestamp": 1762954200, "earningsTimestampStart": 1762954200, "earningsTimestampEnd": 1762954200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.64, "epsForward": -1.51, "epsCurrentYear": -1.49, "priceEpsCurrentYear": -0.7986578, "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]